1. Home
  2. Analysis
  3. Abilify
  4. Potassium-aspartate

Abilify and Potassium aspartate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 8 people who take Abilify and Potassium aspartate. Common interactions include pyrexia among females, and drug-induced liver injury among males.

The phase IV clinical study analyzes what interactions people who take Abilify and Potassium aspartate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 04, 2023

8 people who take Abilify and Potassium aspartate together, and have interactions are studied.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is used in depression. Currently, eHealthMe is studying from 98,584 Abilify users.

What is Potassium aspartate?

Potassium aspartate has active ingredients of aspartates. Currently, eHealthMe is studying from 961 Potassium aspartate users.

Number of Abilify and Potassium aspartate reports submitted per year:

Abilify and Potassium aspartate drug interactions.

Common Abilify and Potassium Aspartate drug interactions by gender *:

female:

  1. Pyrexia
  2. Haemolytic anaemia
  3. Hypogammaglobulinaemia
  4. Hypokalaemia
  5. Hypophagia
  6. Infection
  7. Muscular weakness
  8. Neutropenia
  9. Pancreatitis
  10. Personality change

male:

  1. Drug-induced liver injury

Common Abilify and Potassium Aspartate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Biliary tract infection
  2. Bronchitis
  3. Cholecystitis
  4. Hypophagia
  5. Pancreatitis
  6. Personality change
  7. Pyrexia
  8. Sepsis
  9. Somnolence

60+:

  1. Asthenia
  2. Cardio-respiratory arrest
  3. Procalcitonin increased
  4. Pyrexia
  5. Sepsis
  6. Ventricular fibrillation
  7. White blood cell count decreased
  8. Akathisia
  9. Fall
  10. Fracture

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Potassium aspartate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Common Abilify drug interactions:

Browse interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Potassium aspartate drug interactions:

Browse interactions between Potassium aspartate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and aspartates (the active ingredients of Abilify and Potassium aspartate, respectively), and Abilify and Potassium aspartate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Abilify and Potassium aspartate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.